Dr. Deepak Singla

Dr. Deepak Singla
Country:
Department:
Experience: 9 years of experience
Hospital: Paras Hospitals, Gurgaon

About

About Dr. Deepak Singla Dr. Deepak Singla is an oncologist and hematologist of high repute with 9 years of experience. Dr. Singla is expert in treating breast cancers, GI cancers, hematolymphoid malignancies and lung cancers. He has been conferred with the Visiting Scholar Award at St. Charles Hospital, Toledo (Ohio-USA) and ESMO perceptorship September 2015 (Brussels).  He is a great advocate of cancer screening programs, especially in the rural parts of India. Innumerable cancer awareness programs have been successfully conducted under his able mentorship. Dr. Singla is a member of ASCO, ESMO, ICON, TYACON. He has published a number of articles for the National Journal, India. Dr. Singla studied his MBBS in 2009 followed by post-graduation in internal medicine in 2012 followed by DM (Medical Oncology), ECFMG from USA and PDCR.

List of Treatments

  • Metastatic Tumors Treatment
  • Chemotherapy
  • Radiotherapy
  • Adrenal Cancer Treatment
  • Anal Cancer Treatment
  • Aplastic Anemia
  • Bile Duct Cancer Treatment
  • Bladder Cancer Treatment
  • Bone Cancer Treatment
  • Cancer in Children
  • Carcinoma of Unknown Primary (CUP) Treatment
  • Castleman Disease Treatment
  • Cervical Cancer Treatment
  • Endometrial Cancer Treatment
  • Esophagus Cancer Treatment
  • Ewing Family of Tumors Treatment
  • Eye Cancer Treatment
  • Gallbladder Cancer Treatment
  • Carcinoid Tumors Treatment
  • Gastrointestinal Stromal Tumor GIST Treatment
  • Gestational Trophoblastic Disease (GTD) Treatment
  • Hodgkin Disease Treatment
  • Kaposi Sarcoma Treatment
  • Kidney Cancer Treatment
  • Laryngeal and Hypopharyngeal Cancer Treatment
  • Acute Lymphocytic Leukemia – ALL in Adults
  • Leukemia – Acute Myeloid AML
  • Chronic Lymphocytic Leukemia – CLL
  • Chronic Myeloid Leukemia- CML
  • Chronic Myelomonocytic Leukemia – CMML
  • Leukemia in Children
  • Liver Cancer
  • Lung Cancer Treatment
  • Non-Small Cell Lung Cancer (NSCLC) Treatment
  • Small-cell Carcinoma Treatment
  • Lung Carcinoid Tumor Treatment
  • Skin Lymphoma Treatment
  • Malignant Mesothelioma Treatment
  • Multiple Myeloma Treatment
  • Myelodysplastic Syndrome (MDS) Treatment – Preleukemia
  • Nasal Cavity and Paranasal Sinus Cancer Treatment
  • Nasopharyngeal Cancer Treatment
  • Neuroblastoma
  • Non-Hodgkin Lymphoma (NHL) Treatment
  • Non-Hodgkin Lymphoma In Children
  • Oral Cavity and Oropharyngeal Cancer
  • Osteosarcoma (OS) Treatment
  • Ovarian Cancer Surgery
  • Pancreatic Cancer
  • Penile Cancer Treatment
  • Prostate Cancer-Surgical
  • Retinoblastoma (RB) Treatment
  • Rhabdomyosarcoma (RMS) Treatment
  • Salivary Gland Cancer
  • Soft Tissue Sarcoma Treatment
  • Skin Cancer
  • Basal Cell and Squamous Cell Carcinoma
  • Skin Cancer – Melanoma
  • Small Intestine Cancer Treatment
  • Stomach Cancer Treatment
  • Testicular Cancer Treatment
  • Thymoma and Thymic Carcinoma Treatment
  • Thyroid Cancer Treatment
  • Uterine Sarcoma
  • Vaginal Cancer Treatment
  • Vulvar Cancer Treatment
  • Waldenstrom Macroglobulinemia
  • Wilms Tumor (Nephroblastoma)
  • Breast Biopsy
  • Autologous Stem Cell Transplant for Lymphoma
  • Thalassemia Treatment
  • Breast Cancer
  • Leukemia Treatment
  • Hairy Cell Leukemia – HCL
  • Fallopian Tube Cancer
  • Ovarian Germ Cell Tumor
  • Ovarian Primary Peritoneal Cancer
  • Medullary Carcinoma
  • Papillary Thyroid Cancer Treatment
  • Bone Marrow Cancer
  • Ovarian Sex Cord Stromal Tumor
  • Invasive Lobular Carcinoma
  • Colon Cancer Treatment
  • Cancer Treatment
  • Adenocarcinoma – Glandular Cancer Treatment
  • Immunotherapy

Work Experience

Associate Consultant, Artemis Hospital, Gurgaon

Executive Consultant, Tata Memorial Hospital and ACTREC

, Fortis hospital, Mohali

Special Interest

Bone Marrow Biopsy,
Chemotherapy Administration and Management,
Immunotherapy,
Leukemiamanagement,
Lymphomamanagement,
Myelomamanagement,
Complications arising from Chemotherapy,
PICC insertion,
Targeted Therapy